The formed RAPSI/tGC nanoparticles were accumulated specifically in PC3 tumor tissues, and they released biological active form of siRNA monomers in the cytoplasmic region, resulting in the sequence-specific gene silencing and remarkable tumor growth inhibition with VEGF-targeted siRNA. This evidence concerns the gene TGM2 and neoplasm.